Together with this effect on abnormal keratinocyte proliferation, previous studies indicated that CX-4945 reduced the pro-inflammatory cytokine expression (IL-6, IL-17A, TNF-α) and, in particular, IL-17A, which plays a key role in psoriasis [5] (Figure 2). The gene discussed is IL17A; the disease is psoriasis.